1,7-phenanthroline has been researched along with prazosin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Büyüknacar, HS; Göçmen, C; Kumcu, EK; Onder, S; Singirik, E | 1 |
1 other study(ies) available for 1,7-phenanthroline and prazosin
| Article | Year |
|---|---|
Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
Topics: Adenosine Triphosphate; Animals; Chelating Agents; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Nitric Oxide; Phenanthrolines; Prazosin; Rats; Rats, Wistar; Receptors, Purinergic; Suramin; Vas Deferens | 2005 |